Sarah Ketterer
NVO icon

Sarah Ketterer’s Novo Nordisk NVO Stock Holding History

Sarah Ketterer’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55.3M Sell
1,459,247
-218,368
-13% -$10.1M 0.62% 25
2026
Q2 		$80.4M Buy
1,677,615
+503,402
+43% +$21.6M 0.87% 21
2026
Q1 		$43.2M Buy
1,174,213
+180,363
+18% +$8.55M 0.53% 46
2025
Q4 		$50.6M Buy
993,850
+297,871
+43% +$15.2M 0.7% 38
2025
Q3 		$38.6M Buy
695,979
+342,095
+97% +$20M 0.51% 49
2025
Q2 		$24.4M Buy
+353,884
New +$24.1M 0.39% 56

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Folketrygdfondet
Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Sarah Ketterer's NVO Position: Q3 2026 in Review

Sarah Ketterer reduced its Novo Nordisk (NVO) stake by 13% in Q3 2026, selling an estimated $10.1M and leaving 1,459,247 shares worth $55.3M. The position accounts for 0.62% of the portfolio, ranked #25.

Sarah Ketterer first reported a position in NVO in Q2 2025 and has held it in 6 quarters since. The position peaked at $80.4M in Q2 2026. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Sarah Ketterer held 1,459,247 shares of Novo Nordisk worth $55.3M as of Q3 2026.
  • Sarah Ketterer sold 218,368 Novo Nordisk shares in Q3 2026, an estimated $10.1M.
  • Novo Nordisk made up 0.62% of Sarah Ketterer's portfolio in Q3 2026, its #25 holding.
  • Sarah Ketterer first reported a position in Novo Nordisk in Q2 2025 and has held it in 6 quarters since.
  • Sarah Ketterer's Novo Nordisk position peaked at $80.4M in Q2 2026.
  • 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.